Skip To Main Content
Jiawei Yin on Muck Rack

Jiawei Yin

As seen in: Wiley Online Library, Frontiers, Frontiers in Nutrition, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jiawei

Contact Jiawei, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies

|
By Yikai Liu, Shuai Lu, Jiawei Yin, Pengli Han, Yejun Zha, Xieyuan Jiang
| Frontiers in Nutrition
Abstract Sarcopenia is a disease characterized by reduced muscle mass and strength. In recent years, increasing evidence suggests that gut microbiota (GM) may play an important role in the pathogenesis of sarcopenia. GM is associated with muscle health by affecting muscle metabolism, regulating inflammatory responses, and promoting nutrient absorption.
Open in Who Shared Issue with article?

Data‐Driven Fatigue Prediction of Superalloys: A Novel Strategy Integrating Transfer Learning and Partial Label Learning for Addressing Ambiguous Data

|
By Engineering Hebei, Jiawei Yin, Dayong Wu, Haopeng Lv
| Wiley Online Library Verified
1 Introduction Ni-based superalloys are indispensable in various industrial applications due to their unique high-temperature properties.[1, 2] Fatigue-induced fractures represent a primary failure mode during service and serve as key indicators for evaluating the quality and reliability of these materials.
Open in Who Shared Issue with article?

B7-H7 knockdown suppresses the proliferation, metastasis, and drug resistance of B-cell non-Hodgkin lymphoma cells by inhibiting the PI3K/Akt pathway

|
By Qing Zou, Jiawei Yin, Tao Yan, Xiaoli Xie, Lijuan Wang, Aili Zhai, Shixin Ge, Xingfang Xiong
| Frontiers
Introduction B-cell non-Hodgkin lymphoma (B-NHL) is a common malignant tumor with a heterogeneous origin in the blood system, accounting for approximately 85% of all lymphomas. B-NHL progresses rapidly with a high degree of malignancy (1). The primary treatments for B-NHL include chemotherapy, radiotherapy, immunotherapy, and hematopoietic stem cell transplantation.
Open in Who Shared Issue with article?
See all 13 articles